全文获取类型
收费全文 | 48657篇 |
免费 | 4327篇 |
国内免费 | 5132篇 |
专业分类
58116篇 |
出版年
2024年 | 160篇 |
2023年 | 771篇 |
2022年 | 1576篇 |
2021年 | 2474篇 |
2020年 | 1735篇 |
2019年 | 2268篇 |
2018年 | 2042篇 |
2017年 | 1526篇 |
2016年 | 2186篇 |
2015年 | 3081篇 |
2014年 | 3740篇 |
2013年 | 3833篇 |
2012年 | 4638篇 |
2011年 | 4231篇 |
2010年 | 2670篇 |
2009年 | 2372篇 |
2008年 | 2770篇 |
2007年 | 2462篇 |
2006年 | 2090篇 |
2005年 | 1835篇 |
2004年 | 1568篇 |
2003年 | 1485篇 |
2002年 | 1334篇 |
2001年 | 789篇 |
2000年 | 710篇 |
1999年 | 665篇 |
1998年 | 437篇 |
1997年 | 392篇 |
1996年 | 337篇 |
1995年 | 263篇 |
1994年 | 283篇 |
1993年 | 178篇 |
1992年 | 233篇 |
1991年 | 182篇 |
1990年 | 168篇 |
1989年 | 129篇 |
1988年 | 98篇 |
1987年 | 65篇 |
1986年 | 60篇 |
1985年 | 81篇 |
1984年 | 39篇 |
1983年 | 44篇 |
1982年 | 32篇 |
1981年 | 13篇 |
1980年 | 5篇 |
1979年 | 12篇 |
1977年 | 5篇 |
1975年 | 5篇 |
1971年 | 4篇 |
1965年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin 下载免费PDF全文
Min J Traynor D Stegner AL Zhang L Hanigan MH Alexander H Alexander S 《Eukaryotic cell》2005,4(1):178-189
The drug cisplatin is widely used to treat a number of tumor types. However, resistance to the drug, which remains poorly understood, limits its usefulness. Previous work using Dictyostelium discoideum as a model for studying drug resistance showed that mutants lacking sphingosine-1-phosphate (S-1-P) lyase, the enzyme that degrades S-1-P, had increased resistance to cisplatin, whereas mutants overexpressing the enzyme were more sensitive to the drug. S-1-P is synthesized from sphingosine and ATP by the enzyme sphingosine kinase. We have identified two sphingosine kinase genes in D. discoideum--sgkA and sgkB--that are homologous to those of other species. The biochemical properties of the SgkA and SgkB enzymes suggest that they are the equivalent of the human Sphk1 and Sphk2 enzymes, respectively. Disruption of the kinases by homologous recombination (both single and double mutants) or overexpression of the sgkA gene resulted in altered growth rates and altered response to cisplatin. The null mutants showed increased sensitivity to cisplatin, whereas mutants overexpressing the sphingosine kinase resulted in increased resistance compared to the parental cells. The results indicate that both the SgkA and the SgkB enzymes function in regulating cisplatin sensitivity. The increase in sensitivity of the sphingosine kinase-null mutants was reversed by the addition of S-1-P, and the increased resistance of the sphingosine kinase overexpressor mutant was reversed by the inhibitor N,N-dimethylsphingosine. Parallel changes in sensitivity of the null mutants are seen with the platinum-based drug carboplatin but not with doxorubicin, 5-fluorouracil, and etoposide. This pattern of specificity is similar to that observed with the S-1-P lyase mutants and should be useful in designing therapeutic schemes involving more than one drug. This study identifies the sphingosine kinases as new drug targets for modulating the sensitivity to platinum-based drugs. 相似文献
73.
Lin CT Tsai YC He L Calizo R Chou HH Chang TC Soong YK Hung CF Lai CH 《Journal of biomedical science》2006,13(4):481-488
Summary The HPV oncoproteins E6 and E7 are consistently expressed in HPV-associated cancer cells and are responsible for their malignant transformation. Therefore, HPV E6 and E7 are ideal target antigens for developing vaccines and immunotherapeutic strategies against HPV-associated neoplasms. Recently, it has been demonstrated that codon optimization of the HPV-16 E7 gene resulted in highly efficient translation of E7 and increased the immunogenicity of E7-specific DNA vaccines. Since vaccines targeting E6 also represent an important strategy for controlling HPV-associated lesions, we developed a codon-optimized HPV-16 E6 DNA vaccine (pNGVL4a-E6/opt) and characterized the E6-specific CD8+ T cell immune responses as well as the protective and therapeutic anti-tumor effects in vaccinated C57BL/6 mice. Our data indicated that transfection of human embryonic kidney cells (293 cells) with pNGVL4a-E6/opt resulted in highly efficient translation of E6. In addition, vaccination with pNGVL4a-E6/opt significantly enhanced E6-specific CD8+ T cell immune responses in C57BL/6 mice. Mice vaccinated with pNGVL4a-E6/opt are able to generate potent protective and therapeutic antitumor effects against challenge with E6-expressing tumor cell line, TC-1. Thus, DNA vaccines encoding a codon-optimized HPV-16 E6 may be a promising strategy for improving the potency of prophylactic and therapeutic HPV vaccines with potential clinical implications. 相似文献
74.
Yuanyong Feng Xuedi Cao Bin Zhao Chunyan Song Baoxing Pang Liang Hu Chunmei Zhang Jinsong wang Junqi He Songlin wang 《中国科学:生命科学英文版》2021,(11):1810-1828
Although cisplatin is one of the chemotherapeutics most frequently used in oral squamous cell carcinoma (OSCC) treatment,it exerts multiple side effects and poo... 相似文献
75.
Mindy I. Davis Atsuo T. Sasaki Min Shen Brooke M. Emerling Natasha Thorne Sam Michael Rajan Pragani Matthew Boxer Kazutaka Sumita Koh Takeuchi Douglas S. Auld Zhuyin Li Lewis C. Cantley Anton Simeonov 《PloS one》2013,8(1)
Phosphoinositide kinases regulate diverse cellular functions and are important targets for therapeutic development for diseases, such as diabetes and cancer. Preparation of the lipid substrate is crucial for the development of a robust and miniaturizable lipid kinase assay. Enzymatic assays for phosphoinositide kinases often use lipid substrates prepared from lyophilized lipid preparations by sonication, which result in variability in the liposome size from preparation to preparation. Herein, we report a homogeneous 1536-well luciferase-coupled bioluminescence assay for PI5P4Kα. The substrate preparation is novel and allows the rapid production of a DMSO-containing substrate solution without the need for lengthy liposome preparation protocols, thus enabling the scale-up of this traditionally difficult type of assay. The Z’-factor value was greater than 0.7 for the PI5P4Kα assay, indicating its suitability for high-throughput screening applications. Tyrphostin AG-82 had been identified as an inhibitor of PI5P4Kα by assessing the degree of phospho transfer of γ-32P-ATP to PI5P; its inhibitory activity against PI5P4Kα was confirmed in the present miniaturized assay. From a pilot screen of a library of bioactive compounds, another tyrphostin, I-OMe tyrphostin AG-538 (I-OMe-AG-538), was identified as an ATP-competitive inhibitor of PI5P4Kα with an IC50 of 1 µM, affirming the suitability of the assay for inhibitor discovery campaigns. This homogeneous assay may apply to other lipid kinases and should help in the identification of leads for this class of enzymes by enabling high-throughput screening efforts. 相似文献
76.
Yongjing He Zhenjun Deng Mansour Alghamdi Lechun Lu Mark W. Fear Li He 《Cell proliferation》2017,50(2)
Keloid scarring is a dermal fibroproliferative response characterized by excessive and progressive deposition of collagen; aetiology and molecular pathology underlying keloid formation and progression remain unclear. Genetic predisposition is important in the pathogenic processes of keloid formation, however, environmental factors and epigenetic mechanisms may also play pivotal roles. Epigenetic modification is a recent area of investigation in understanding the molecular pathogenesis of keloid scarring and there is increasing evidence that epigenetic changes may play a role in induction and persistent activation of fibroblasts in keloid scars. Here we have reviewed three epigenetic mechanisms: DNA methylation, histone modification and the role of non‐coding RNAs. We also review the evidence that these mechanisms may play a role in keloid formation ‐ in future, it may be possible that epigenetic markers may be used instead of prognostic or diagnostic markers here. However, there is a significant amount of work required to increase our current understanding of the role of epigenetic modification in keloid disease. 相似文献
77.
Mitochondrial impairment is hypothesized to contribute to the pathogenesis of chronic cholestatic liver diseases. Mitofusin 2 (Mfn2) regulates mitochondrial morphology and signaling and is involved in the development of numerous mitochondrial-related diseases; however, a functional role for Mfn2 in chronic liver cholestasis which is characterized by increased levels of toxic bile acids remain unknown. Therefore, the aims of this study were to evaluate the expression levels of Mfn2 in liver samples from patients with extrahepatic cholestasis and to investigate the role Mfn2 during bile acid induced injury in vitro. Endogenous Mfn2 expression decreased in patients with extrahepatic cholestasis. Glycochenodeoxycholic acid (GCDCA) is the main toxic component of bile acid in patients with extrahepatic cholestasis. In human normal hepatocyte cells (L02), Mfn2 plays an important role in GCDCA-induced mitochondrial damage and changes in mitochondrial morphology. In line with the mitochondrial dysfunction, the expression of Mfn2 decreased significantly under GCDCA treatment conditions. Moreover, the overexpression of Mfn2 effectively attenuated mitochondrial fragmentation and reversed the mitochondrial damage observed in GCDCA-treated L02 cells. Notably, a truncated Mfn2 mutant that lacked the normal C-terminal domain lost the capacity to induce mitochondrial fusion. Increasing the expression of truncated Mfn2 also had a protective effect against the hepatotoxicity of GCDCA. Taken together, these findings indicate that the loss of Mfn2 may play a crucial role the pathogenesis of the liver damage that is observed in patients with extrahepatic cholestasis. The findings also indicate that Mfn2 may directly regulate mitochondrial metabolism independently of its primary fusion function. Therapeutic approaches that target Mfn2 may have protective effects against hepatotoxic of bile acids during cholestasis. 相似文献
78.
采用全基因分段合成和补丁连接相结合的方法构建了人甲状旁腺素 (hPTH) (1~ 34)肽基因 ,并利用GST融合表达系统 ,在大肠杆菌中克隆和可溶性表达了hPTH(1~ 34)肽基因。融合蛋白表达量占菌体总蛋白质的 2 5 %以上 ,经高密度发酵、亲和纯化后 ,在每升发酵液中得到了 10 g融合蛋白。融合蛋白经肠激酶一步加工并亲合纯化和反相脱盐后 ,最终可以得到约 0 .6g /L人甲状旁腺素 (1~ 34)肽纯品 ,样品的理论回收值达到了4 8.75 %。产物的纯度和性质经HPLC、毛细管电泳、质谱分析、N端测序等得到证明 ,并与化学合成产物的结果相吻合。兔肾皮质细胞测活表明 ,重组产物与化学合成人甲状旁腺素 (1~ 34)肽具有相近的腺苷酸环化酶激活活性。 相似文献
79.
Zhang?Lijuan Jifu?Liu Hao?Zhang Shanshan?Wu Lingyun?Huang Dacheng?He Xueyuan?XiaoEmail author 《中国科学C辑(英文版)》2005,48(6):641-647
There are multiple reports of autoimmune response in patients with lung cancer. To investigate whether a novel autoantibody
is present in patients with lung cancer and evaluate its clinical diagnostic and prognostic value, sera from 10 patients with
lung cancer and 10 normal individuals were analyzed using immunofluorescence and Western blotting. It was found that one serum
sample from the patients with squamous carcinoma gave a fine speckled pattern staining in nucleus and had a high titer antinuclear
autoantibody which could recognize 31 kD of nuclear protein isolated from both cancer cells and normal cells. The same patient’s
serum was further used to immunoprecipitate the target antigen. The protein bands were excised from the SDS-PAGE gels and
were analyzed with a Qstar Pulser I Quadrupole time-flight mass spectrometer, and the 31 kD target antigen was identified
as U1-AsnRNP. To test the prevalence of anti-U1-AsnRNP antibody, sera from 93 patients including 36 squmaous carcinomas (SCC),
26 adenocarcinomas (Ad), and 31 small cell carcinomas (SCLC) were screened by Western blotting. The results demonstrated that
anti-U1-A snRNP antibody was present in 50% of SCC sera, 26.9% of Ad sera and 54.8% of SCLC sera. In this paper, we report
for the first time that anti-U1-AsnRNP antibody could be detected in the patients with lung cancer. 相似文献
80.
We collected a specimen of Chinese Pygmy Dormouse (Typhlomys cinereus)from Nanling Nature Reserve in Guangdong Province in August 2012,analyzed the specimen’s morphological and skull indices,and compared them with the published data for other T. cinereus subspecies located throughout China. The skull of our specimen had four pairs of palatal holes:among them,the two posterior pairs merged together to form two large and long holes,and the posterior edge of the nasals was located vertically below the frontopremaxillary suture. Based on these two unique characteristics,we identified the specimen as the subspecies T. c. daloushanensis. This is the first time this species has been recorded in Guangdong Province. 相似文献